Pediatric Nonalcoholic Fatty Liver Disease in 2009

Journal of Pediatrics

Volumn 155, Issue 4, 2009, Pages 469-474

  Alisi, Anna ^a   Manco, Melania ^a   Vania, Andrea ^b   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; COMORBIDITY; FAMILY; FEEDING BEHAVIOR; HEALTH PROMOTION; HUMAN; LIFESTYLE; LIVER FAILURE; LIVER FIBROSIS; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR;

CHILD; FATTY LIVER; HEPATITIS; HUMANS; INSULIN RESISTANCE; OBESITY; RISK FACTORS;

EID: 70249094340     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.06.014     Document Type: Article

References (96)

1. Wang Y., and Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1 (2006) 11-25
2. World Health Organisation. Physical status: the use and interpretation of anthropometry (1995), WHO, Geneva
3. World Health Organisation. Obesity, preventing and managing the global epidemic: report of a WHO consultation (2000), WHO Technical Report Series, No. 894, Geneva
4. Cole T.J., Bellizzi M.C., Flegal K.M., and Dietz W.H. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320 (2000) 1240-1246
5. Barshop N.J., Sirlin C.B., Schwimmer J.B., and Lavine J.E. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther 28 (2008) 13-24
6. Patton H.M., Sirlin C., Behling C., Middleton M., Schwimmer J.B., and Lavine J.E. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 43 (2006) 413-427
7. Moran J.R., Ghishan F.K., Halter S.A., and Greene H.L. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78 (1983) 374-377
8. Ong J.P., and Younossi Z.M. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11 (2007) 1-16
9. Papandreou D., Rousso I., and Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin Nutr 26 (2007) 409-415
10. Maclaren N.K., Gujral S., Ten S., and Motagheti R. Childhood obesity and insulin resistance. Cell Biochem Biophys 48 (2007) 73-78
11. Dunn W., and Schwimmer J.B. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 10 (2008) 67-72
12. Manco M., Bottazzo G., DeVito R., Marcellini M., Mingrone G., and Nobili V. Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27 (2008) 667-676
13. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 11 (2007) 191-207
14. Wieckowska A., and Feldstein A.E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28 (2008) 386-395
15. Patton H.M., Lavine J.E., Van Natta M.L., Schwimmer J.B., Kleiner D., Molleston J., et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 135 (2008) 1961-1971
16. Kashi M.R., Torres D.M., and Harrison S.A. Current and emerging therapies in nonalcoholic fatty liver disease. Semin Liver Dis 28 (2008) 396-406
17. Kinugasa A., Tsunamoto K., Furukawa N., Sawada T., Kusunoki T., and Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 3 (1984) 408-414
18. Franzese A., Vajro P., Argenziano A., Puzziello A., Iannucci M.P., Saviano M.C., et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42 (1997) 1428-1432
19. Strauss R.S., Barlow S.E., and Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 136 (2000) 727-733
20. Schwimmer J.B., McGreal N., Deutsch R., Finegold M.J., and Lavine J.E. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115 (2005) e561-e565
21. Fishbein M.H., Mogren C., Gleason T., and Stevens W.R. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 42 (2006) 83-88
22. Nakao K., Nakata K., Ohtsubo N., Maeda M., Moriuchi T., Ichikawa T., et al. Association between nonalcoholic fatty liver, markers of obesity, and serum leptin level in young adults. Am J Gastroenterol 97 (2002) 1796-1801
23. Manco M., Bedogni G., Marcellini M., Devito R., Ciampalini P., Sartorelli M.R., et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 57 (2008) 1283-1287
24. Manco M., Marcellini M., Devito R., Comparcola D., Sartorelli M.R., and Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 32 (2008) 381-387
25. Chan D.F., Li A.M., Chu W.C., Chan M.H., Wong E.M., Liu E.K., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 (2004) 1257-1263
26. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., and Lavine J.E. Obesity, insulin resistance, and other clinicopathological correlations of pediatric nonalcoholic fatty liver disease. J Pediatr 143 (2003) 500-505
27. Kawasaki T., Hashimoto N., Kikuchi T., Takahashi H., and Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 24 (1997) 317-321
28. Weiss R., Dziura J., Burgert T.S., Tamborlane W.V., Taksali S.E., Yeckel C.W., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
29. Kocak N., Yuce A., Gurakan F., and Ozen H. Obesity: a cause of steatohepatitis in children. Am J Gastroenterol 95 (2000) 1099-1100
30. Perseghin G., Bonfanti R., Magni S., Lattuada G., De Cobelli F., Canu T., et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291 (2006) E697-E703
31. Louthan M.V., Barve S., McClain C.J., and Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr 147 (2005) 835-838
32. Nobili V., Manco M., Ciampalini P., Diciommo V., Devito R., Piemonte F., et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 155 (2006) 735-743
33. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., and Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 118 (2006) 1388-1393
34. Ogden C.L., Flegal K.M., Carroll M.D., and Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288 (2002) 1728-1732
35. Williams D.E., Cadwell B.L., Cheng Y.J., Cowie C.C., Gregg E.W., Geiss L.S., et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 116 (2005) 1122-1126
36. Comuzzie A.G., Funahashi T., Sonnenberg G., Martin L.J., Jacob H.J., Black A.E., et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86 (2001) 4321-4325
37. Lee S., Bacha F., Gungor N., and Arslanian S.A. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 29 (2006) 51-56
38. Arslan N., Buyukgebiz B., Ozturk Y., and Cakmakci H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 47 (2005) 23-27
39. Guzzaloni G., Grugni G., Minocci A., Moro D., and Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 24 (2000) 772-776
40. Manton N.D., Lipsett J., Moore D.J., Davidson G.P., Bourne A.J., and Couper R.T. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 173 (2000) 476-479
41. Rashid M., and Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30 (2000) 48-53
42. Schwimmer J.B., Behling C., Newbury R., Deutsch R., Nievergelt C., Schork N.J., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (2005) 641-649
43. Mager D.R., and Roberts E.A. Nonalcoholic fatty liver disease in children. Clin Liver Dis 10 (2006) 109-131
44. Lonardo A., Carani C., Carulli N., and Loria P. "Endocrine NAFLD" a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 44 (2006) 1196-1207
45. Cook J.S., Hoffman R.P., Stene M.A., and Hansen J.R. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 77 (1993) 725-730
46. Roemmich J.N., Clark P.A., Lusk M., Friel A., Weltman A., Epstein L.H., et al. Pubertal alterations in growth and body composition, VI: pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release. Int J Obes Relat Metab Disord 26 (2002) 701-709
47. Goran M.I., and Gower B.A. Longitudinal study on pubertal insulin resistance. Diabetes 50 (2001) 2444-2450
48. Kimata H. Increased incidence of fatty liver in non-obese Japanese children under 1 year of age with or without atopic dermatitis. Public Health 120 (2006) 176-178
49. Roberts E.A. Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 10 (2005) 2306-2318
50. Nanda K. Non-alcoholic steatohepatitis in children. Pediatr Transplant 8 (2004) 613-618
51. Siegelman E.S., and Rosen M.A. Imaging of hepatic steatosis. Semin Liver Dis 21 (2001) 71-80
52. Manco M., Bottazzo G., DeVito R., Marcellini M., Mingrone G., and Nobili V. Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27 (2008) 667-676
53. Nobili V., Reale A., Alisi A., Morino G., Trenta I., Pisani M., et al. Elevated serum ALT in children presenting to the emergency unit: relationship with NAFLD. Dig Liver Dis (2009 Apr 9) [Epub ahead of print]
54. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (2005) 1898-1906
55. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
56. Fishbein M.H., Mogren C., Gleason T., and Stevens W.R. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 42 (2006) 83-88
57. Pacifico L., Celestre M., Anania C., Paolantonio P., Chiesa C., and Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr 96 (2007) 542-547
58. Manco M., and Nobili V. Utilità of MRI in the evaluation of hepatic fat content. Hepatology 50 (2009) 328-329
59. Wieckowska A., and Feldstein A.E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28 (2008) 386-395
60. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., Zeuzem S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134 (2008) 960-974
61. Nobili V., Vizzutti F., Arena U., Abraldes J.G., Marra F., Pietrobattista A., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48 (2008) 442-448
62. Harrison S.A., Oliver D., Arnold H.L., Gogia S., and Neuschwander-Tetri B.A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57 (2008) 1441-1447
63. Angulo P., Hui J.M., Marchesini G., Bugianesi E., George J., Farrell G.C., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45 (2007) 846-854
64. Cales P., Laine F., Boursier J., Deugnier Y., Moal V., Oberti F., et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 50 (2009) 165-173
65. Ratziu V., Massard J., Charlotte F., Messous D., Imbert-Bismut F., Bonyhay L., et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 6 (2006) 6
66. Guha I.N., Parkes J., Roderick P., Chattopadhyay D., Cross R., Harris S., et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47 (2008) 455-460
67. Nobili V., Parkes J., Bottazzo G., Marcellini M., Cross R., Newman D., et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136 (2009) 160-167
68. Yilmaz Y., Ulukaya E., and Dolar E. The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond. Hepatology 49 (2009) 1056-1057
69. Huang M., Greenson J.K., Chao C., Anderson L., Peterman D., Jacobson J., et al. One-year intense nutritional counseling results in histologic improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100 (2005) 1072-1078
70. Nobili V., Manco M., Devito R., Di Ciommo V., Comparcola D., Sartorelli M.R., et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48 (2008) 119-128
71. Spieth L.E., Harnish J.D., Lenders C.M., Raezer L.B., Pereira M.A., Hangen S.J., et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 154 (2000) 947-951
72. Roberts E.A., and Yap J. Nonalcoholic Fatty Liver Disease (NAFLD): approach in the adolescent patient. Curr Treat Options Gastroenterol 9 (2006) 423-431
73. Grattagliano I., Vendemiale G., Caraceni P., Domenicali M., Nardo B., Cavallari A., et al. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J Nutr 130 (2000) 2131-2136
74. Wu A., Sun X., Wan F., and Liu Y. Modulations by dietary restriction on antioxidant enzymes and lipid peroxidation in developing mice. J Appl Physiol 94 (2003) 947-952
75. Preiss D., and Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 115 (2008) 141-150
76. International Pediatric Endosurgery Group Standards and Safety Committee. IPEG guidelines for surgical treatment of extremely obese adolescents. J Laparoendosc Adv Surg Tech A 18 (2008) xiv-xvi
77. Dufour J.F., Oneta C.M., Gonvers J.J., Bihl F., Cerny A., Cereda J.M., et al. Randomized placebo controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 4 (2006) 1537-1543
78. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 136 (2000) 734-738
79. Vajro P., Mandato C., Franzese A., Ciccimarra E., Lucariello S., Savoia M., et al. Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J Pediatr Gastroenterol Nutr 38 (2004) 48-55
80. Nobili V., Manco M., Devito R., Ciampalini P., Piemonte F., and Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 24 (2006) 1553-1561
81. Lindor K.D., Kowdley K.V., Heathcote E.J., Harrison M.E., Jorgensen R., Angulo P., et al. Ursodeoxycholic acid for treatment of non-alcoholic steatohepatitis: results of a randomized trial. Hepatology 39 (2004) 770-778
82. Vajro P., Franzese A., Valerio G., Iannucci M.P., and Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 136 (2000) 739-743
83. Jones K.L., Arslanian S., Peterokova V.A., Park J.S., and Tomlinson M.J. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25 (2002) 89-94
84. Zuhri-Yafi M.I., Brosnan P.G., and Hardin D.S. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 15 Suppl 1 (2002) 541-546
85. Schwimmer J.B., Middleton M.S., Deutsch R., and Lavine J.E. A phase 2 clinical trial of metformin as a treatment for nondiabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (2005) 871-879
86. Bugianesi E., Gentilcore E., Manini R., Natale S., Vanni E., Villanova N., et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100 (2005) 1082-1090
87. Nobili V., Manco M., Ciampalini P., Alisi A., Devito R., Bugianesi E., et al. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Clin Ther 30 (2008) 1168-1176
88. Miyazaki Y., Mahankali A., Matsuda M., Mahankali S., Hardies J., Cusi K., et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87 (2002) 2784-2791
89. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., Oliver D., and Bacon B.R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38 (2003) 1008-1017
90. Juurinen L., Kotronen A., Graner M., and Yki-Jarvinen H. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. J Clin Endocrinol Metab 93 (2008) 118-124
91. Belfort R., Harrison S.A., Brown K., Darland C., Finch J., Hardies J., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355 (2006) 2297-2307
92. Loguercio C., Federico A., Tuccillo C., Terracciano F., D'Auria M.V., De Simone C., et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39 (2005) 540-543
93. Oz H.S., Im H.J., Chen T.S., de Villiers W.J., and McClain C.J. Glutathione-enhancing agents protect against steatohepatitis in a dietary model. J Biochem Mol Toxicol 20 (2006) 39-47
94. Ekstedt M., Franzén L.E., Mathiesen U.L., Holmqvist M., Bodemar G., and Kechagias S. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol 47 (2007) 135-141
95. Loguercio C., Federico A., Trappoliere M., Tuccillo C., de Sio I., Di Leva A., et al. The effect of a silybin-vitamin phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci 52 (2007) 2387-2395
96. Vinciguerra M., Sgroi A., Veyrat-Durebex C., Rubbia-Brandt L., Buhler L.H., and Foti M. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology 49 (2009) 1176-1184